Valuation: Mega Lifesciences

Market Cap 32.7B 979M 857M 790M 731M 1.39B 93.46B 1.41B 9.46B 3.71B 45.89B 3.68B 3.6B 159B P/E 2026 *
14.1x
P/E 2027 * 13.3x
Enterprise Value 28.08B 841M 736M 678M 628M 1.19B 80.28B 1.21B 8.12B 3.19B 39.42B 3.16B 3.09B 137B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.79x
Free-Float
38.61%
Yield 2026 *
4.66%
Yield 2027 * 5%
1 day+1.35%
1 week-0.66%
Current month+2.04%
1 month+6.38%
3 months+10.29%
6 months+1.35%
Current year+11.94%
1 week 36.5
Extreme 36.5
38
1 month 33.75
Extreme 33.75
38
Current year 31.5
Extreme 31.5
40
1 year 25.75
Extreme 25.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25Buy

Chief Executive Officer

100,000 0.0115%
28/04/25Buy

Chief Executive Officer

150,000 0.0172%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%-0.66%+38.89%-0.66% 962M
-0.08%-0.10%+54.10%+167.60% 1,084B
-1.72%-1.45%+65.87%+62.51% 634B
-1.34%-4.72%+30.50%+84.96% 447B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-1.27%-2.91%+27.42%+44.91% 285B
-0.93%-3.57%-27.74%-39.70% 218B
-1.20%-3.11%+22.25%+61.31% 199B
-0.73%+2.46%+18.77%+77.70% 169B
Average -1.22%+2.20%+28.80%+51.63% 366.08B
Weighted average by Cap. -1.24%+2.48%+38.66%+83.76%

Financials

2026 *2027 *
Net sales 14.88B 446M 390M 359M 333M 631M 42.53B 642M 4.3B 1.69B 20.88B 1.67B 1.64B 72.34B 15.61B 468M 409M 377M 349M 662M 44.63B 673M 4.52B 1.77B 21.92B 1.76B 1.72B 75.91B
Net income 2.32B 69.48M 60.78M 56.05M 51.86M 98.43M 6.63B 100M 671M 263M 3.26B 261M 255M 11.28B 2.46B 73.67M 64.44M 59.43M 54.99M 104M 7.03B 106M 712M 279M 3.45B 277M 271M 11.96B
Net Debt -4.61B -138M -121M -111M -103M -196M -13.18B -199M -1.33B -523M -6.47B -518M -507M -22.42B -4.76B -142M -125M -115M -106M -202M -13.6B -205M -1.38B -539M -6.68B -535M -523M -23.13B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
09/07/26 THB 37.50 +1.35% 457,501
08/07/26 THB 37.00 -1.99% 1,334,709
07/07/26 THB 37.75 -0.66% 541,492
06/07/26 THB 38.00 +0.66% 1,022,371
03/07/26 THB 37.75 +0.67% 734,293
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.50THB
Average target price
41.14THB
Spread / Average Target
+9.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock